BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
BRCA1
,
Angiogenesis
,
HIV infection
,
Hippocampus
,
Amniocentesis
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PAM
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Heart atrium
Parotid gland
Heart
Aorta
Salivary gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Peptidylglycine α-amidating monooxygenase is required for atrial secretory granule formation.
PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes …
PAM variants were associated with type 2 diabetes mellitus risk in the Chinese population.
PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.
PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors
Position and Angle Marking System (PAMS) for Ultrasound-guided Neuraxial Procedures
A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Acti…
Partners at Meals - Respite Care and Home (PAM)
Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ